Focus: Conception is a Berkeley-based biotechnology company specializing in the conversion of cells into eggs, operating at the intersection of cell therapy and women's health. The company is publicly listed with a focused pipeline in reproductive biology and related therapeutic areas.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Conception presents a high-risk, high-differentiation opportunity suitable only for scientists betting on a transformative cell therapy platform in women's health, but with significant visibility gaps on pipeline, financials, and growth trajectory.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Conception
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Conception's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
8-K Filing: Stablecoin Development Corp (SDEV) (CIK 0001389545) — EXHIBIT 10.2
EXHIBIT 10.2
8-K Filing: Sadot Group Inc. (SDOT) (CIK 0001701756) — EXHIBIT 10.1
EXHIBIT 10.1
8-K Filing: Chiron Real Estate Inc. (XRN, XRN-PA, XRN-PB) (CIK 0001533615) — EXHIBIT 10.4
EXHIBIT 10.4
8-K Filing: AtaiBeckley Inc. (ATAI) (CIK 0002081043) — EXHIBIT 2.1
EXHIBIT 2.1
8-K Filing: LIPELLA PHARMACEUTICALS INC. (LIPO) (CIK 0001347242) — EX-2.2
EX-2.2
8-K Filing: Rocky Mountain Chocolate Factory, Inc. (RMCF) (CIK 0001616262) — OFFER LETTER, DATED JULY 8, 2026, BY AND BETWEEN ROCKY MOUNTAIN CHOCOLATE FACTORY, INC., AND ALLEN C. HARPER
OFFER LETTER, DATED JULY 8, 2026, BY AND BETWEEN ROCKY MOUNTAIN CHOCOLATE FACTORY, INC., AND ALLEN C. HARPER
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo